Mayo Clinic news - Researchers at Mayo Clinic’s campus in Jacksonville and Virginia Tech in Blacksburg, Va., through their technology commercialization efforts, have licensed compounds to AstraZeneca for potential new drug therapies to treat depression. The collaboration advances both the development of novel compounds and supports ongoing research by Mayo and Virginia Tech in the [...]
AP - Drugmaker AstraZeneca PLC said Monday it launched its drug Seroquel XR as a treatment for bipolar disorder in addition to a previous approval for schizophrenia.
The London-based company will sell Seroquel XR as a treatment for depressive, manic and mixed episodes of bipolar I disorder, as well as schizophrenia in adults, and acute schizophrenic [...]
BP TODAY - Tricyclic antidepressants may induce mood conversions in bipolar disorder, according to a new retropective study done in Poland.
The aim of this retrospective study was an analysis of antidepressant-induced mood conversions to mania/hypomania occurring in bipolar inpatients treated with antidepressants in the Affective Disorder Unit of the Institute of Psychiatry and Neurology, Warsaw, [...]
BP TODAY - Thyroid hormone triiodothyronine (T3) may help hard-to-treat patients with bipolar disorder and depression, as an augmentation agent in existing treatments, a new study says.
The study was carried out by scientists at the Depression & Bipolar Clinic of Colorado. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar [...]
BP TODAY - A team of French scientists have identified 8 risk factors associated with lifetime suicide attempts of bipolar patients from a France national cohort.
Risk factors that may be associated with suicide attempts in bipolar disorder are still a matter of debate. The researchers compared demographic, illness course, clinical, and temperamental features of suicide [...]
Reuters - A widely available blood pressure pill could one day help people erase bad memories, perhaps treating some anxiety disorders and phobias, according to a Dutch study published on Nature Neuroscience.
The generic beta-blocker propranolol significantly weakened people’s fearful memories of spiders among a group of healthy volunteers who took it, said Merel Kindt, a [...]
Social isolation affects how people behave as well as how their brains operate, a study at the University of Chicago shows.
The research, presented Sunday at a symposium, “Social Emotion and the Brain,” at the annual meeting of the American Association for the Advancement of Science, is the first to use fMRI scans to study the [...]
Mayo Clinic — In a study published in The American Journal of Psychiatry, a team of researchers led by Mayo Clinic psychiatrist Mark Frye, M.D., attempted to identify what factors make some people with bipolar depression more likely to experience treatment-emergent mania (TEM).
Bipolar disorder, also known as manic-depressive illness, is a mental illness characterized by [...]
Press release - Alkermes, Inc. announced that the Food and Drug Administration (FDA) has asked Alkermes’ partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), for additional information regarding the supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® ((risperidone) Long-Acting Injection). The sNDA, submitted in April 2008, sought approval for RISPERDAL CONSTA for adjunctive [...]
